LogiPharma Europe

Joydeep Ganguly, SVP, corporate operations, interim CIO, Gilead Sciences, shares how stakeholders can drive meaningful, lasting impact by turning pledges into proof points, exercising patience, and embedding sustainability into core business operations.

Joydeep Ganguly, SVP, corporate operations, interim CIO, Gilead Sciences, shares insights on how sustainability has evolved from a compliance requirement to a key business strategy, driving operational efficiencies, innovation, and long-term growth.

Will Robinson, program director, LogiPharma, shares how in-depth conversations—not AI—drive the research behind one of the industry's most anticipated annual agendas.

Will Robinson, program director, LogiPharma, explains how artificial intelligence and sustainability are driving a clear shift in priorities across the pharmaceutical supply chain.

Will Robinson, program director, LogiPharma, reveals why the conference will be moved to Vienna moving forward.

A panel discussion uncovers ways to deliver personalized therapy ops in a timely fashion.

Steffen Lang, president, operations, executive committee member, Novartis, discusses what to expect from Novartis over the next decade in terms of technological innovations.

Steffen Lang, president, operations, executive committee member, Novartis, discusses how technology will continue to enhance operations and how it will impact patients.

Steffen Lang, president, operations, executive committee member, Novartis, shares strategic insights on how pharma supply chain leaders can elevate operations to drive innovation, growth, and patient impact.

How can stakeholders prepare for changing therapy requirements?

A keynote presentation describes how supply chain visibility should rely on digital capabilities.

Steffen Lang, president, operations, executive committee member, Novartis, discusses the premise of a keynote session on reimagining operations.

A panel discussion breaks down ways for stakeholders to meet temperature-controlled operational demands pertaining to product pipelines.

The conference’s opening keynote case study shares ways to elicit change that not only results in business growth and productivity, but a boost in patient connection as well.

The conference returns to Lyon, France and promises a timely and relevant agenda that attendees will resonate with.

Kevin Lynch, Vice President of Global Sales at QProducts & Services, dives into the role of sustainability in pharmaceutical packaging.

In an interview with Pharma Commerce Editor Nicholas Saraceno at LogiPharma Europe, Nick Porter, President, World Courier discusses mitigating supply chain risks, the future of artificial intelligence in pharma logistics, and more.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Cathy O'Brien, VP of Sales, UPS Healthcare discusses current technology that the pharma industry is adopting when it comes to sustainability.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Cathy O'Brien, VP of Sales, UPS Healthcare discusses her masterclass on delivering agility in supply chains by building a multimodal cold chain network while also reducing risks at LogiPharma Europe 2024.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Martin Hawes, Global Head of Product Development, Tower Cold Chain offers insights on the future of cell & gene therapies when it comes to cold chain storage.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Will Robinson, Commercial Director, LogiPharma, talks themes of this year's event and future plans for the show.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Will Robinson, Commercial Director, LogiPharma, discusses the process of keeping the event relevant to the times.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, suggests how to improve visibility and risk management for cold chain shipping.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, offers his thoughts on how changing customer needs are affecting cold chain logistics.

Panel discussion addresses how DE&I can successfully tackle systemic biases and more.

Session addresses the challenges of implementing autologous/allogeneic cell gene therapies into scalable networks.

A panel uncovers the value in meeting carbon-neutral goals by 2030.

Panel discussion uncovers how to alter one’s digital know-how for use in temperature-controlled supply chain.

Masterclass session addresses looking beyond a dashboard by added capabilities with added value.

From logistics lessons learned, how pharma can navigate new opportunities surfacing in ocean shipping.